{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:15:33Z","timestamp":1648656933694},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.eimc.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T19:14:26Z","timestamp":1533064466000},"page":"484-485","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors for fosfomycin resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection"],"prefix":"10.1016","volume":"37","author":[{"given":"Javier","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Bastida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Smithson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.eimc.2018.06.015_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0924-8579(03)00228-0","article-title":"Febrile urinary tract infection in men","author":"Ulleryd","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2018.06.015_bib0060","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.06.015_bib0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s10096-015-2493-8","article-title":"Differential characteristics of healthcare-associated compared to community acquired febrile urinary tract infections in males","volume":"34","author":"Smithson","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2018.06.015_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","article-title":"Resurgence of an old companion","volume":"22","author":"Sastry","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.eimc.2018.06.015_bib0075","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.02611-15","article-title":"Long-term fosfomycin-tromethamine oral therapy for difficult-to-treat chronic bacterial prostatitis","volume":"60","author":"Los-Arcos","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2018.06.015_bib0080","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2018.06.015_bib0085","first-page":"43","article-title":"Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005\u20132009\u20132011)","volume":"26","author":"Rodr\u00edguez-Avial","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.eimc.2018.06.015_bib0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijmm.2017.09.019","article-title":"Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection","volume":"307","author":"Pourbaix","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.eimc.2018.06.015_bib0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eimc.2017.10.013","article-title":"Trend and seasonality of community-acquired Escherichia coli antimicrobial resistance and its dynamic relationship with antimicrobial use assessed by ARIMA models","volume":"38","author":"Asencio Egea","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2018.06.015_bib0100","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3201\/eid2309.170560","article-title":"Emergence of plasmid-mediated fosfomycin-resistance genes among Escherichia coli isolates, France","volume":"23","author":"Benzerara","year":"2017","journal-title":"Emerg Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18302283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18302283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T08:43:51Z","timestamp":1564217031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X18302283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0213005X18302283"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2018.06.015","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors for fosfomycin resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}